CAMP FY 2023 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$350,000

Gross Profit

$350,000100.0% margin

Operating Income

-$52M-14822.6% margin

Net Income

-$49M-14083.1% margin

EPS (Diluted)

$-4.07

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$45M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$55M

Total Liabilities

$179M

Stockholders' Equity

-$124M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$350,000	$0	—
Gross Profit	$350,000	$0	—
Operating Income	-$52M	-$45M	-15.3%
Net Income	-$49M	-$44M	-11.5%